Skip to content

DOKTER TOM MOERMAN

Active Private limited companyfounded 2020active for 6 yearsBuffelstraat 12, 9000 GhentKBO/BCE: BE 0753.841.339

Lifetime

5 annual accounts with figures on one time axis
peak of €812,960 in 2022
€627,219▼ 1.0%
peak of €608,601 in 2022
€470,061▼ 1.1%
peak of €1.2m in 2023
€110,061▼ 81.0%
€1.3m▲ 49.1%
Board1 name since 2020
1 director
Documentsfilings and deeds
09-07-202622 days before the deadline
2025micro format
Dividend €938,996Equity from €578,996 to €110,061Debts from €858,225 to €1.3mInvestments €7,868

Key points

from the 2025 annual accounts

Equity

€110,061 from €1.2m in 2023

Equity fell by 91% in 2 years.

Turnover

≈ €940,000 estimated

The micro format states no turnover.

Debts

€1.3m 92% of the balance sheet
Suppliers 0%Taxes and wages 2%Other 98%

Of this, €1.3m falls due within a year.

Investments

€7,868 2.8 times depreciation
202120222025

Green is investment, beige is depreciation.

Filings

5 annual accounts 1 late
AprilJune31 JulyOctober20222024

The 2023 accounts came 27 days late. The other four were filed on time.

Position in the sector

7.9%

Lower solvency than 87% of companies in human health. Sector median 63.0% · 21,337 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 875 companies had the same profile as DOKTER TOM MOERMAN has now. Each dot stands for 3 companies, two years later.

96.6%
were still trading
1.9%
stopped another way
1.4%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 875 companies, not a prediction for DOKTER TOM MOERMAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-09-2020
  • founderdeed of 11-09-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0753841339
Incorporation Founding capital of €10,000 · Founded by · appointed as director · Founder: · published on 11-09-2020 · Gazette deed
First establishment President Kennedylaan 4, Kortrijk
All 11 events

Comparable companies

same main activity, similar in size and age
Company
DOKTER TOM MOERMAN Ghent €1.4m €627,219 7.9% -
De Huidkliniek bv Koksijde €1.5m €582,288 15.0% -
New Vision Oogpraktijk Laakdal €1.4m €688,003 -8.1% 5.9
Soscia GL Mons €1.4m €549,650 75.0% -
Pathologie CVD Ghent €1.3m €690,953 41.9% -
DR. RUBEN DE GROOTE – UROLOOG Sint-Martens-Latem €1.5m €547,377 99.1% -
PGS Deinze €1.1m €672,422 99.9% -

These companies have the same main activity as DOKTER TOM MOERMAN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.1m and €1.5m, founded between 2020 and 2022.

Official details

Source: KBO
Status
Active since 09-09-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.306.732.6508500 Kortrijk, since 09-09-2020
Financial year end
31 December
Peppol
Reachable since 29-12-2025
Company details

Annual accounts 2025

€1.4m▼ 3.3%
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Insights on DOKTER TOM MOERMAN

DOKTER TOM MOERMAN files the micro format. That format states no turnover. The gross margin rose from €114,716 in 2021 to €627,219 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER TOM MOERMAN

What is the company number of DOKTER TOM MOERMAN?
The company number of DOKTER TOM MOERMAN is 0753.841.339. The VAT number is the same number with BE in front: BE 0753.841.339.
Where is DOKTER TOM MOERMAN based?
The registered office is at Buffelstraat 12, 9000 Ghent.Company details
What does DOKTER TOM MOERMAN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER TOM MOERMAN?
DOKTER TOM MOERMAN is a private limited company (BV).
When was DOKTER TOM MOERMAN founded?
DOKTER TOM MOERMAN was founded on 09-09-2020.
Is DOKTER TOM MOERMAN still active?
Yes, DOKTER TOM MOERMAN is an active enterprise in the KBO register.
What is the turnover of DOKTER TOM MOERMAN?
The turnover in financial year 2025 is ≈ €940,000. This figure is estimated from the gross margin of €627,219 and 31 comparable companies (NACE 86220). It probably lies between €840,000 and €1.3m.Financials
Is DOKTER TOM MOERMAN profitable?
In financial year 2025, DOKTER TOM MOERMAN made a profit of €470,061.
Where can I find the annual accounts of DOKTER TOM MOERMAN?
DOKTER TOM MOERMAN filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER TOM MOERMAN due?
DOKTER TOM MOERMAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.